AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
AI and big data/analytics are identified by healthcare industry professionals as the top technologies that will transform pharmaceutical drug discovery and development processes, according to a survey by GlobalData, a leading data and analytics company. Healthcare industry professionals revealed that 28% of pharmaceutical companies will be using AI and big data/analytics to optimize drug discovery and development processes in the next two years and 32% of companies will rely on big data/analytics to streamline sales and marketing.
‘Artificial intelligence (AI) and data analytics play a major role in optimizing pharmaceutical drug discovery and development processes.’
Urte Jakimaviciute, Senior Director of Market Research at GlobalData, comments: “The pharmaceutical industry is data driven. With the increasing volume and complexity of data being generated by the sector from multiple sources, the need to organize and streamline information is a constant challenge”.The use of analytics data to extract from patient records and registries, real-world evidence, sales and marketing, and connected devices will be used to design treatment plans, develop drugs, or improve clinical trial outcomes.
The data-generating areas of healthcare are wearables, electronic healthcare records, remote patient monitoring and mobile apps.
The increasing use of social and digital media tools among physicians and patients has also contributed to increasing volumes and variety of information that companies can access, collect, and analyze.
Data analytics in pharma companies provide better insights into end-users' behavior patterns, response to marketing campaigns, product performance, and upcoming industry trends that which can result in improved marketing and sales if comprehensively analysed and interpreted.
Advertisement
AI requires high-quality data, and the more data AI receives, the more accurate and efficient it can become. If companies do not have full visibility into data quality, they cannot trust the results that AI generates.
Advertisement
Source-Medindia